LMO7DN
LMO7 downstream neighbor protein
Also known as: LMO7D_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for LMO7DN in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
122 residues, UniProt reviewed canonical sequence.
>F2Z398|LMO7DN
1 MTWLDKGVWT QEDENSCSFS ESDFPGCRDQ INPSIPSIWT AVSGMMISLE VRWWIKGKQG
61 YVISLGHALS PRLECSGTFS AHCILGLPGG SSYPPASVSQ VVGTTALYLV EEAWAEAGKM
121 RSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LMO7DN can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.7
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LMO7DN as an antibody target. Whether an autoantibody or antibody against LMO7DN could matter depends on whether native LMO7DN is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LMO7DN is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label LMO7DN as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...